These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10442499)

  • 1. Interleukin-1beta and recombinant human erythropoietin therapy.
    Takemasa A; Yorioka N
    Clin Nephrol; 1999 Jul; 52(1):61-2. PubMed ID: 10442499
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of recombinant human erythropoietin on interleukin-1 beta and interleukin-6 in patients on maintenance hemodialysis.
    Sayinalp N; Erdem Y; Haznedaroğlu IC; Dündar S; Cağlar S; Kirazli S
    Clin Nephrol; 1995 Dec; 44(6):404. PubMed ID: 8719556
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients.
    Costa E; Swinkels DW; Laarakkers CM; Rocha-Pereira P; Rocha S; Reis F; Teixeira F; Miranda V; do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
    Acta Haematol; 2009; 122(4):226-9. PubMed ID: 19887781
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythropoietin treatment in renal anemia. How high should the target hematocrit be?
    Minetti L
    J Nephrol; 1997; 10(3):117-9. PubMed ID: 9238619
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypothyroidism and resistance to human recombinant erythropoietin.
    Touam M; Guéry B; Goupy C; Menoyo V; Drüeke T
    Nephrol Dial Transplant; 2004 Apr; 19(4):1020-1. PubMed ID: 15031379
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythropoietin-resistant refractory renal anemia: effects of oral L-carnitine supplementation.
    Kawabata M; Kasuga S; Hara H; Suyama S; Moriyama K; Takabatake T
    Clin Nephrol; 2001 Mar; 55(3):265-6. PubMed ID: 11316253
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythropoietin and its use in renal failure.
    Sulková S; Krajhanzl A
    EDTNA ERCA J; 1996; 22(1):suppl 1-7; quiz 8. PubMed ID: 10723310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
    Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S
    Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target hemoglobin level for EPO therapy in CKD.
    Parfrey PS
    Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399
    [No Abstract]   [Full Text] [Related]  

  • 10. An unusual etiology of erythropoietin resistance: hyperthyroidism.
    Kaynar K; Ozkan G; Erem C; Gul S; Yilmaz M; Sonmez B; Ozdemir F; Ulusoy S
    Ren Fail; 2007; 29(6):759-61. PubMed ID: 17763175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial estimation of serum interleukin 6 during treatment with recombinant human erythropoietin in patients with the anemia of rheumatoid arthritis.
    Jongen-Lavrencic M; Swaak AJ; Vreugdenhil G
    J Rheumatol; 1993 Jul; 20(7):1253-5. PubMed ID: 8371234
    [No Abstract]   [Full Text] [Related]  

  • 12. Pure red cell aplasia followed by disseminated intravascular coagulation in a haemodialysis patient receiving erythropoietin-beta.
    Manenti L; Vaglio A
    Nephrol Dial Transplant; 2007 May; 22(5):1465-7. PubMed ID: 17337465
    [No Abstract]   [Full Text] [Related]  

  • 13. [What are the aims and targets of renal anemia therapy?].
    Eckardt KU
    Dtsch Med Wochenschr; 2007 Sep; 132(36):1837-41. PubMed ID: 17726657
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythropoietin resistance in the treatment of the anemia of chronic renal failure.
    Priyadarshi A; Shapiro JI
    Semin Dial; 2006; 19(4):273-8. PubMed ID: 16893403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension in a pregnancy with renal anemia after recombinant human erythropoietin (rhEPO) therapy.
    Kashiwagi M; Breymann C; Huch R; Huch A
    Arch Gynecol Obstet; 2002 Nov; 267(1):54-6. PubMed ID: 12410378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of anemia in dialysis patients in France (1998-1999) (Study by ESAM-France)].
    Jacobs C;
    Nephrologie; 2002; 23(2):85-91. PubMed ID: 12012753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin: has treatment reached its full potential?
    Fishbane S
    Semin Dial; 2006; 19(1):1-4. PubMed ID: 16423172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indications and limits of recombinant human erythropoietin in intensive care unit].
    Ventré C; Rousseau S; Albanèse J; Leone M; Martin C
    Ann Fr Anesth Reanim; 2004 Jul; 23(7):714-21. PubMed ID: 15324960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do hemodialysis patients need higher doses of erythropoietin if given intravenously rather than subcutaneously?
    McMahon LP
    Nat Clin Pract Nephrol; 2006 May; 2(5):246-7. PubMed ID: 16932434
    [No Abstract]   [Full Text] [Related]  

  • 20. 2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.
    Gejyo F; Saito A; Akizawa T; Akiba T; Sakai T; Suzuki M; Nishi S; Tsubakihara Y; Hirakata H; Bessho M;
    Ther Apher Dial; 2004 Dec; 8(6):443-59. PubMed ID: 15663544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.